-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, TBz4Gi9B99NG/SIjxHo8jyPBTBYk8MQzFcI+irxHqQ/oqMdYSPFRWTUMrT/69lDj qfyfeZUbTaZRs49fskwo3w== 0001225208-10-015100.txt : 20100614 0001225208-10-015100.hdr.sgml : 20100614 20100614143539 ACCESSION NUMBER: 0001225208-10-015100 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100611 FILED AS OF DATE: 20100614 DATE AS OF CHANGE: 20100614 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Simpson Curran CENTRAL INDEX KEY: 0001346164 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14169 FILM NUMBER: 10894515 MAIL ADDRESS: STREET 1: 14200 SHADY GROVE ROAD CITY: ROCKVILLE STATE: MD ZIP: 20850 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HUMAN GENOME SCIENCES INC CENTRAL INDEX KEY: 0000901219 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 223178468 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 14200 SHADY GROVE ROAD CITY: ROCKVILLE STATE: MD ZIP: 20850-3338 BUSINESS PHONE: 3013098504 MAIL ADDRESS: STREET 1: 14200 SHADY GROVE ROAD CITY: ROCKVILLE STATE: MD ZIP: 20850 4 1 doc4.xml X0303 4 2010-06-11 0000901219 HUMAN GENOME SCIENCES INC HGSI 0001346164 Simpson Curran 14200 SHADY GROVE ROAD ROCKVILLE MD 20850 1 Sr. VP, Operations Common Stock 2010-06-11 4 M 0 18461 9.78 A 43742 D Common Stock 2010-06-11 4 S 0 18461 26.066 D 25281 D Employee Stock Option - Right to Buy 9.78 2010-06-11 4 M 0 18461 0 D 2013-04-22 Common Stock 18461 19616 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and Charles Schwab effective 5/3/10. This transaction was executed in multiple trades at prices ranging from $26.00 to $26.13. The price reported above reflects the weighted average sale price. Upon written request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price is available. These options have vested and are fully exercisable. James H. Davis, Pursuant to Power of Attorney 2010-06-14 -----END PRIVACY-ENHANCED MESSAGE-----